MDT Financial Facts
Cash dividends declared per common share: 0.31Research and development expense: 373M
See Full Income Statement
Total liabilities and shareholders' equity: 55.23B
Long-term deferred tax liabilities, net: 415M
See Full Balance Sheet
Medtronic, Inc. (MDT) Earnings
|
Expand Research on MDT
| Next EPS Date | 5/23/24 | EPS Growth Rate | -7.6% |
|---|---|---|---|
| Average EPS % Beat Rate | +4.6% | Revenue Growth Rate | -0.7% |
| Average % Move 1-Wk after EPS | -0.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/25/20 | Q121 | $0.62 | $0.18 | +$0.44 | $6.5B | $5.44B | N/A |  | | Details | |
8/23/11  |
 |
Q112 | $0.79 | $0.79 | $0.00 | $4.05B | $3.98M | N/A | | | Details |
| 11/24/20 | |
Q221 | $1.02 | $0.80 | +$0.22 | $7.65B | $7.07B | N/A | | | Details |
| 11/23/10 |
|
Q211 | $0.82 | $0.81 | +$0.01 | N/A | N/A | = | | | Details |
| 11/22/11 |
|
Q212 | $0.84 | $0.82 | +$0.02 | $4.13B | $4.07B | N/A | | | Details |
| 2/22/11 |
|
Q311 | $0.86 | $0.84 | +$0.02 | $3.96B | $3.97B | = | | | Details |
| 2/21/12 |
|
Q312 | $0.84 | $0.84 | $0.00 | $3.92B | $3.99B | N/A | | | Details |
| 8/21/12 |
|
Q113 | $0.85 | $0.85 | $0.00 | $4.01B | $4.01B | = | | | Details |
